It's only the beginning. The demand for New Era medicine as advanced by Berkeley Bio -- formulators of medicinal options that harmonize with endocannabinoid receptors in the human body toward the restoration, support, and maintenance of good health -- is the new game-changing paradigm. Big Pharma has had its day.

And SKTO, parent of Berkeley Bio, is in the sweet spot. .